Megan Seivert
Psychiatric/Mental Health · Reno, NVNPI 1992262778
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,090 and has fallen 62.7% since, to $407 in 2025.
Across 165 payments — averaging $22.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$873
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$533
- Otsuka America Pharmaceutical, Inc.$378
- Neurocrine Biosciences, Inc.$300
- Johnson & Johnson$230
- Indivior Inc.$214
- plus $1K from 12 others
What the payments were for
- Food & beverage$3,70799%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $873 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $533 |
| Otsuka America Pharmaceutical, Inc. | 15 | $378 |
| Neurocrine Biosciences, Inc. | 10 | $300 |
| Johnson & Johnson | 5 | $230 |
| Indivior Inc. | 12 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $197 |
| Teva Pharmaceuticals USA, Inc. | 24 | $184 |
| Sunovion Pharmaceuticals Inc. | 10 | $160 |
| E.r. Squibb & Sons, L.L.C. | 2 | $152 |
| Axsome Therapeutics, Inc. | 3 | $152 |
| Vanda Pharmaceuticals Inc. | 5 | $104 |
| Lundbeck LLC | 5 | $102 |
| Alkermes, Inc. | 3 | $68 |
| Braeburn Inc. | 2 | $38 |
| Eisai Inc. | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Luye Pharma (USA) Ltd. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$252
- VRAYLAR$235
- INGREZZA$140
- INVEGA SUSTENNA$129
- ABILIFY ASIMTUFII$123
- ABILIFY MAINTENA$123
- COBENFY$119
- Auvelity$114
How this compares
$3,754 in reported general payments places this provider in the 85th percentile of 362 psychiatric/mental health providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 13 | $18,215 |
| Doxepin Hcl | 12 | $295 |
| Quetiapine Fumarate | 15 | $87 |
| Benztropine Mesylate | 12 | $81 |
| Venlafaxine Hcl | 11 | $63 |
| Diazepam | 14 | $35 |
| Alprazolam | 13 | $23 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $873 | $18,21513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 362 psychiatric/mental health providers in Nevada.
Other psychiatric/mental health in Reno
- Okechukwu OlisaReno$7K
- Kaiwen JiangReno$6K
- Alana RogneReno$6K
- Doris AnukamReno$5K
- Denis WilliamsReno$4K
- Nathanael MellumReno$3K
- Jacqueline WilliamsReno$3K
- Michelle GiddingsLas Vegas$131K
- Patrick ApiladoLas Vegas$19K
- Joshua HamiltonLas Vegas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.